20/11/11 20:26:59.02 YwY/1FsA9.net
Pfizer's CEO cashed out 60% of his stock on the same day the company unveiled the results of its COVID-19 vaccine trial
Pfizer chief executive Albert Bourla sold 62% of his stock in the company on the same day the drugmaker announced the results of its COVID-19 vaccine trial.
Bourla sold $5.6 million in stock on Monday as part of a predetermined trading plan adopted on August 19.
His stock sale was carried out at $41.94 a share. The 52-week-high for Pfizer stock is $41.99, which means the CEO cashed out his shares close to their highest this year.
Pfizer and its German partner BioNTech are the first to post positive results from pivotal COVID-19 vaccine trials.
URLﾘﾝｸ(markets.businessinsider.com)